Cycle Physiology · Hormonal Regulation
Energy intake and appetite in laboratory and free-living conditions may be consistent across menstrual cycle phases
Smith M et al., 2026
252 works
Jerilynn C Prior
Professor, Medicine - Endocrinology, University of British Columbia
ORCID LoopSciProfilesCentre for Menstrual Cycle and Ovulation Research
Regularly publishes research on Progesterone and Progestins, Fracture Risk Factors, and Osteoporosis Diagnosis and Treatment.
Subjects
252 works
Breast Health · Benign Breast Conditions
Breast tenderness and swelling experiences related to menstrual cycles and ovulation in healthy premenopausal women: Secondary analysis of the 1-year "Prospective Ovulation Cohort"
Wood M et al., 2025
Energy Intake and Appetite in Laboratory and Free-Living Conditions are Consistent Across Menstrual Cycle Phases
Purcell SA et al., 2025
Feeling of self-worth in healthy premenopausal women-relationships with menstrual cycles and ovulation over 1-year in the prospective ovulation cohort
Shirazian N et al., 2025
Ibuprofen for menstrual cramps
Prior J, 2025
Breast Health · Benign Breast Conditions
MON-154 Breast areolar diameter in healthy menstruating women—a single cycle cross-sectional study of associations with body size and ovulatory characteristics
Baaske AV et al., 2025
Cycle Physiology · Hormonal Regulation
Ovulatory and anovulatory cycle phase influences on QT interval dynamics during the menstrual cycle
Naderi B et al., 2025
Breast Health · Benign Breast Conditions
SAT-128 Prospective 1-year Menstrual CycleBreast Tenderness and Swelling Experiences—data from healthy regularly cycling women initially proven normally ovulatory on two consecutive cycles
Wood M et al., 2025
Hormonal Agents · Progesterone and Progestins
SUN-109 Feasibility of Cyclic Progesterone and Spironolactone for PCOS-specific Health-Related Quality of Life—a six-month, Phase II, single arm, single center, open-label study
Nelson K et al., 2025
Cycle Disorders · Amenorrhea
Associations of Early Prolonged Secondary Amenorrhea in Women With and Without HIV
Swann SA et al., 2024
Author Correction: Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial
Prior JC et al., 2024
Bone Mineral Density · Measurement
Longitudinal Assessment of Bone Mineral Density in Women Living With and Without HIV Across Reproductive Phases
Swann SA et al., 2024
Cycle Disorders · Dysmenorrhea
Menstrual Cramps in Anovulatory versus Normally Ovulatory Cycles - SARS-COV-2 Pandemic Daily Data Plus a Meta-Analysis of Cramps and Anovulation
Mann G et al., 2024
Cycle Physiology · Cycle Variability
Prospective 1-year assessment of within-woman variability of follicular and luteal phase lengths in healthy women prescreened to have normal menstrual cycle and luteal phase lengths
Henry S et al., 2024
Gynecologic Oncology · Endometrial Cancer
Recognizing Endometrial Cancer Risks in Perimenopausal and Postmenopausal Experiences: Insights From Community Qualitative Interviews and Workshop
Ibrahim M et al., 2024
Reproductive Aging · Ovarian Aging
Age at Natural Menopause in Women Living with HIV: A Cross-Sectional Study Comparing Self-Reported and Biochemical Data
Swann SA et al., 2023
Hormones and Bone · Contraceptive Effects on Bone
Bone health and prevalent fractures in women with polycystic ovary syndrome: a meta-analysis and endocrine-context pathophysiology review
Prior JC et al., 2023
Hormones and Bone · Contraceptive Effects on Bone
Combined hormonal contraceptive use is not protective against musculoskeletal conditions or injuries: a systematic review with data from 5 million females
White L et al., 2023
Hormone Therapy · Benefits and Risks
Don't ignore perimenopause
Prior JC et al., 2023
Cycle Disorders · Ovulatory Disturbances
Experiences of women living with Polycystic Ovary Syndrome: A pilot case-control, single-cycle, daily Menstrual Cycle Diary study during the SARS-CoV-2 pandemic
Nelson K et al., 2023
Breast Health · Breast Cancer Risk
Lack of evidence that progesterone in ovulatory cycles causes breast cancer
Gompel A et al., 2023
Bone Mineral Density · Measurement
Long-Term Change in Bone Mineral Density in Women Living With HIV: A 10-Year Prospective Controlled Cohort Study
Macdonald HM et al., 2023
Ovarian Hormones · Estrogen
Lower anti-Müllerian hormone levels are associated with HIV in reproductive age women and shorter leukocyte telomere length among late reproductive age women
Van Ommen CE et al., 2023
Hormone Therapy · Benefits and Risks
Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial
Prior JC et al., 2023
Nutrition and Metabolic Health · Dietary Patterns
Vitamin D intakes among women living with and without HIV in Canada
King EM et al., 2023
Neuroendocrinology · Hypothalamic Amenorrhea
Adaptive, reversible, hypothalamic reproductive suppression: More than functional hypothalamic amenorrhea
Prior JC, 2022
Study Design · Cohort Studies
Assessing the role of adolescent hormonal contraceptive use on risk for depression: a 3-year longitudinal study protocol
Zareian B et al., 2022
Family Planning Use and Attitudes · Method Use and Prevalence
Factors associated with contraceptive use among women living with HIV in Canada: a controlled, cross-sectional study
Khondoker CC et al., 2022
Prevalence of ocular anomalies is increased in women with polycystic ovary syndrome-exploration of association with PAX6 genotype
Zong Z et al., 2022
Prospective analyses of sex/gender-related publication decisions in general medical journals: editorial rejection of population-based women's reproductive physiology
Kalidasan D et al., 2022
Bone Mineral Density · Measurement
Reply to: The Association Between Cognitive Decline and Bone Loss and Fracture Risk Is Not Affected by Medication With Anticholinergic Effect
Bliuc D et al., 2022
Transition Physiology · Symptom Patterns
Resilience and psychosocial factors linked to symptom experience during the menopause transition for women living with HIV
King EM et al., 2022
Ovarian Hormones · Progesterone
Women’s Menstrual Cycles and Ovulation Provide Balanced Estradiol and Progesterone for Fertility and Lifelong Health
Prior JC, 2022 Book chapter
Hormonal Agents · Progesterone and Progestins
"Phase II 6-month Cyclic Progesterone/Spironolactone pilot Therapy Trial in Polycystic Ovary Syndrome : pre-post, single-arm feasibility study"
Prior JC et al., 2021
Study Design · Cohort Studies
British Columbia CARMA-CHIWOS Collaboration (BCC3): protocol for a community-collaborative cohort study examining healthy ageing with and for women living with HIV
Swann SA et al., 2021
Osteoporosis · Diagnosis and Treatment
Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study
Bliuc D et al., 2021
Cyclic progesterone and spironolactone treatment for androgenic polycystic ovary syndrome
Prior JC et al., 2021
Ovarian Hormones · Progesterone
Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)-A 6-Month Pilot Study of a Single Woman's Experience Changes
Shirin S et al., 2021
Sexual Function · Libido and Desire
Does Interest in Sex Peak at Mid-Cycle in Ovulatory Menstrual Cycles of Healthy, Community-Dwelling Women? An 11-month Prospective Observational Study
Macbeth AB et al., 2021
Hormonal Agents · Estrogen Preparations
Menopausal hormone therapy for women living with HIV
King EM et al., 2021
Osteoporosis · Diagnosis and Treatment
Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility study
Billington EO et al., 2021
Osteoporosis · Diagnosis and Treatment
Vertebral Fractures: Which Radiological Criteria Are Better Associated With the Clinical Course of Osteoporosis?
Lentle BC et al., 2021
Diagnostic Criteria and Classification · Diagnostic Criteria
Where's the break? Critique of radiographic vertebral fracture diagnostic methods
Prior JC et al., 2021
Fracture Risk · Risk Factors
A Risk Assessment Tool for Predicting Fragility Fractures and Mortality in the Elderly
Tran T et al., 2020
Balanced actions of estradiol and progesterone—A new paradigm of women’s reproductive health
Prior JC, 2020
Fracture Risk · Risk Factors
Combining Frailty and Trabecular Bone Score Did Not Improve Predictive Accuracy in Risk of Major Osteoporotic Fractures
Li G et al., 2020
Bone Mineral Density · Measurement
Deficits in bone strength, density and microarchitecture in women living with HIV: A cross-sectional HR-pQCT study
Macdonald HM et al., 2020
Osteoporosis · Diagnosis and Treatment
Differences in fracture prevalence and in bone mineral density between Chinese and White Canadians: the Canadian Multicentre Osteoporosis Study (CaMos)
Morin SN et al., 2020
Hormonal Agents · Progesterone and Progestins
Effects of progesterone therapy on serum sclerostin levels in healthy menopausal women: a 3-month randomized, placebo-controlled clinical trial
Yang YB et al., 2020
Hot flashes? Night sweats? Progesterone can help reduce symptoms of menopause
Prior JC, 2020 Preprint
Environmental Exposures · Endocrine Disrupting Chemicals
Menstrual cycle phases and exposure to environmental contaminants : Menstrual Cycle and Ovulation Study 2 (MOS2)
Prior JC et al., 2020
Ovarian Hormones · Progesterone
MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
Shirin S et al., 2020
Ovarian Hormones · Progesterone
MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
Shirin S et al., 2020
Paradigm shift in pathophysiology of vasomotor symptoms: Effects of estradiol withdrawal and progesterone therapy
Fan Y et al., 2020
Postpartum Lactational Amenorrhea and Recovery of Reproductive Function and Normal Ovulatory Menstruation
Prior JC, 2020 Book chapter
Bone Mineral Density · Measurement
Prolonged Amenorrhea and Low Hip Bone Mineral Density in Women Living With HIV-A Controlled Cross-sectional Study
King EM et al., 2020
Fracture Risk · Risk Factors
Testing a theoretical model of imminent fracture risk in elderly women: an observational cohort analysis of the Canadian Multicentre Osteoporosis Study
Papaioannou A et al., 2020
The central role of ovulatory disturbances in the etiology of androgenic polycystic ovary syndrome (PCOS)—Evidence for treatment with cyclic progesterone
Briden L et al., 2020
Fracture Risk · Risk Factors
Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone
Koromani F et al., 2020
Ovarian Hormones · Progesterone
Women’s reproductive system as balanced estradiol and progesterone actions—a revolutionary, paradigm-shifting concept in women’s health
Prior JC, 2020
Bone Mineral Density · Measurement
322. Prolonged Amenorrhea Is Associated with Decreased Hip Bone Mineral Density in Women Living with HIV
King EM et al., 2019
Guideline Appraisal · Evidence Base and Strength of Recommendation
Adolescent combined hormonal contraceptives and surgical repair of anterior cruciate tears: a risky recommendation based on an unproven causal relationship
Prior J et al., 2019
Bone Mineral Density · Peak Bone Mass
Adolescent use of combined hormonal contraception and peak bone mineral density accrual: A meta-analysis of international prospective controlled studies
Goshtasebi A et al., 2019
Fracture Risk · Risk Factors
Frailty and Risk of Fractures in Patients With Type 2 Diabetes
Li G et al., 2019
Osteoporosis · Diagnosis and Treatment
Incident Fragility Fractures Have a Long-Term Negative Impact on Health-Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study
Borhan S et al., 2019
Osteoporosis · Diagnosis and Treatment
Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study
Hopman WM et al., 2019
MON-LB042 Health-Related Quality of Life in Women with Polycystic Ovary Syndrome/Anovulatory Androgen Excess versus Local Population-Based Control Women (from the British Columbia Canadian Multicentre Osteoporosis Study [BC CaMos])
Liang B et al., 2019
Prescribing Safety · Off-Label Prescribing
Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study
Bliuc D et al., 2019
Fracture Risk · Risk Factors
Parity and lactation are not associated with incident fragility fractures or radiographic vertebral fractures over 16 years of follow-up: Canadian Multicentre Osteoporosis Study (CaMos)
Cooke-Hubley S et al., 2019
Fracture Risk · Risk Factors
Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian Multicentre Osteoporosis Study (CaMos)
Adachi JD et al., 2019
Hormonal Agents · Progesterone and Progestins
Progesterone Is Important for Transgender Women's Therapy-Applying Evidence for the Benefits of Progesterone in Ciswomen
Prior JC, 2019
Bone Mineral Density · Measurement
Reduced Bone Loss Is Associated With Reduced Mortality Risk in Subjects Exposed to Nitrogen Bisphosphonates: A Mediation Analysis
Bliuc D et al., 2019
Response to Letter to the Editor: "Progesterone Is Important for Transgender Women's Therapy-Applying Evidence for the Benefits of Progesterone in Ciswomen"
Prior JC, 2019
Hormonal Agents · Progesterone and Progestins
SUN-537 Progesterone Therapy and Serum Sclerostin Levels in Healthy Menopausal Women: A 3-month Randomized, Placebo Controlled Clinical Trial
Yang Y et al., 2019
Osteoporosis · Diagnosis and Treatment
The Radiology of Osteoporotic Vertebral Fractures Revisited
Lentle B et al., 2019
Hormones and Bone · Estrogen and Bone
Adult Premenopausal Bone Health Related to Reproductive Characteristics-Population-Based Data from the Canadian Multicentre Osteoporosis Study (CaMos)
Goshtasebi A et al., 2018
Bone Mineral Density · Peak Bone Mass
Combined hormonal contraceptives use and bone mineral density changes in adolescent and young women in a prospective population-based Canada-wide observational study
Brajic TS et al., 2018
Osteoporosis · Diagnosis and Treatment
Comparative Analysis of the Radiology of Osteoporotic Vertebral Fractures in Women and Men: Cross-Sectional and Longitudinal Observations from the Canadian Multicentre Osteoporosis Study (CaMos)
Lentle BC et al., 2018
Cycle Biomarkers · Hormonal Markers
Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
Prior JC et al., 2018
Hormones and Bone · Estrogen and Bone
Innovations in Women's Bone Health-Appreciating Important "Bone Variables" Besides Estrogen
Prior JC, 2018
Bone Mineral Density · Measurement
Premature Spinal Bone Loss in Women Living with HIV is Associated with Shorter Leukocyte Telomere Length
Kalyan S et al., 2018
Hormonal Agents · Progesterone and Progestins
Progesterone for the prevention and treatment of osteoporosis in women
Prior JC, 2018
Hormone Therapy · Benefits and Risks
Progesterone for treatment of symptomatic menopausal women
Prior JC, 2018
Osteoporosis · Diagnosis and Treatment
Vertebral Fractures and Morphometric Deformities
Lentle BC et al., 2018
Bone Mineral Density · Measurement
Women's Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)
Wong EMM et al., 2018
Bone Mineral Density · Measurement
Competing Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a Toll
Kalyan S et al., 2017
Bone Mineral Density · Measurement
Densitometer-Specific Differences in the Correlation Between Body Mass Index and Lumbar Spine Trabecular Bone Score
Mazzetti G et al., 2017
Hormones and Bone · Estrogen and Bone
Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization
Prior JC et al., 2017
Hormones and Bone · Adolescent Bone Accrual
HOW CAN WE PROTECT PEAK BONE MASS AND FUTURE BONE HEALTH FOR ADOLESCENT WOMEN? - BY SUPPORTING OVULATION AND AVOIDING COMBINED HORMONAL CONTRACEPTION USE
Prior JC, 2017
Measurement and Statistics · Instrument Development and Validation
Latent variable mixture models to test for differential item functioning: a population-based analysis
Wu X et al., 2017
Physical Activity · Exercise and Ovulation
Patterns and predictors of sitting time over ten years in a large population-based Canadian sample: Findings from the Canadian Multicentre Osteoporosis Study (CaMos)
Gebel K et al., 2017
Fracture Risk · Risk Factors
Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality
Tran T et al., 2017
Oral Contraceptives · Metabolic Effects
Adolescents’ use of combined hormonal contraceptives for menstrual cycle–related problem treatment and contraception: evidence of potential lifelong negative reproductive and bone effects
Prior JC, 2016
Reproductive Ethics · Conscience Protections
Apply the Precautionary Principle Concerning Combined Hormonal Contraception Use in Adolescents
Prior JC, 2016
Nutrition and Metabolic Health · Dietary Patterns
Dietary patterns in men and women are simultaneously determinants of altered glucose metabolism and bone metabolism
Langsetmo L et al., 2016
Measurement and Statistics · Instrument Development and Validation
Differential Item Functioning in the SF-36 Physical Functioning and Mental Health Sub-Scales: A Population-Based Investigation in the Canadian Multicentre Osteoporosis Study
Lix LM et al., 2016
Biological Aging Markers · Telomeres
Endocrine abnormalities in HIV-infected women are associated with peak viral load - the Children and Women: AntiRetrovirals and Markers of Aging (CARMA) Cohort
Sokalski KM et al., 2016
Cycle Disorders · Abnormal Uterine Bleeding
Health Care Provider Hormonal Recommendations for Treatment of Menstrual Cycle-related Problems - A Vignette-Based Study
Chen R et al., 2016
Bone Mineral Density · Measurement
Premenopausal Trabecular Bone Loss is Associated with a Family History of Fragility Fracture
Prior JC et al., 2016
Fracture Risk · Risk Factors
Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function
Naylor KL et al., 2016
Bone Mineral Density · Peak Bone Mass
Associations of Protein Intake and Protein Source with Bone Mineral Density and Fracture Risk: A Population-Based Cohort Study
Langsetmo L et al., 2015
Hormones and Bone · Estrogen and Bone
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers
Berger C et al., 2015
Cycle Physiology · Ovulation
Ovulation Prevalence in Women with Spontaneous Normal-Length Menstrual Cycles - A Population-Based Cohort from HUNT3, Norway
Prior JC et al., 2015
Perimenopause and menopause as oestrogen deficiency while ignoring progesterone
Prior JC, 2015
Hormonal Agents · Progesterone and Progestins
Progesterone or progestin as menopausal ovarian hormone therapy: recent physiology-based clinical evidence
Prior JC, 2015
Fracture Risk · Risk Factors
Ten-year incident osteoporosis-related fractures in the population-based Canadian Multicentre Osteoporosis Study - comparing site and age-specific risks in women and men
Prior JC et al., 2015
Fracture Risk · Risk Factors
A meta-analysis of the association of fracture risk and body mass index in women
Johansson H et al., 2014
Fracture Risk · Risk Factors
Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS)
Moura C et al., 2014
Bone Mineral Density · Measurement
Choice of lumbar spine bone density reference database for fracture prediction in men and women: a population-based analysis
Leslie WD et al., 2014
Fracture Risk · Risk Factors
Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period
Fraser LA et al., 2014
Fracture Risk · Risk Factors
Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos)
Ioannidis G et al., 2014
Hormones and Bone · Estrogen and Bone
Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles
Li D et al., 2014
Hormonal Agents · Progesterone and Progestins
Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women
Prior JC et al., 2014
Progesterone Within Ovulatory Menstrual Cycles Needed for Cardiovascular Protection: An Evidence-Based Hypothesis
Prior JC, 2014
Prospectively measured 10-year changes in health-related quality of life and comparison with cross-sectional estimates in a population-based cohort of adult women and men
Hopman WM et al., 2014
Nutrition and Metabolic Health · Dietary Patterns
Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos)
Langsetmo L et al., 2013
Fracture Risk · Risk Factors
Fracture risk prediction: importance of age, BMD and spine fracture status
Krege JH et al., 2013
Bone Mineral Density · Peak Bone Mass
Longitudinal changes in calcium and vitamin D intakes and relationship to bone mineral density in a prospective population-based study: the Canadian Multicentre Osteoporosis Study (CaMos)
Zhou W et al., 2013
Bone Mineral Density · Peak Bone Mass
Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women
Koller DL et al., 2013
Hormonal Agents · Progesterone and Progestins
Progesterone therapy increases free thyroxine levels--data from a randomized placebo-controlled 12-week hot flush trial
Sathi P et al., 2013
Long Term Health · Cardiovascular Health
Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women
Hitchcock CL et al., 2012
Hormone Therapy · Bioidentical Hormones
Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women
Hitchcock CL et al., 2012
Diagnostic Criteria and Classification · Terminology and Definitions
Osteoporosis-related fracture case definitions for population-based administrative data
Lix LM et al., 2012
Bone Mineral Density · Measurement
Physical activity, body mass index and bone mineral density-associations in a prospective population-based cohort of women and men: the Canadian Multicentre Osteoporosis Study (CaMos)
Langsetmo L et al., 2012
Fracture Risk · Risk Factors
Predicting fracture using 2D finite element modelling
MacNeil JA et al., 2012
Hormone Therapy · Benefits and Risks
Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound
Prior JC et al., 2012
Hormones and Bone · Estrogen and Bone
Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels
Berger C et al., 2012
Bone Mineral Density · Measurement
The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos)
Targownik LE et al., 2012
Ovarian Hormones · Androgens
Acute effects of premenopausal hysterectomy with bilateral oophorectomy on serum lipids, hormonal values, inflammatory markers and metabolism
Kalyan S et al., 2011
Fracture Risk · Risk Factors
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts
Leslie WD et al., 2011
Fracture Risk · Risk Factors
Dietary patterns and incident low-trauma fractures in postmenopausal women and men aged ≥ 50 y: a population-based cohort study
Langsetmo L et al., 2011
Premenstrual Disorders · Cyclical Symptom Patterns
Fluid Retention over the Menstrual Cycle: 1-Year Data from the Prospective Ovulation Cohort
White CP et al., 2011
Fracture Risk · Risk Factors
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos
Fraser LA et al., 2011
Osteoporosis · Diagnosis and Treatment
Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study
Fraser LA et al., 2011
Fracture Risk · Risk Factors
Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture
Langsetmo L et al., 2011
Hormone Therapy · Bioidentical Hormones
Progesterone for Symptomatic Perimenopause Treatment - Progesterone politics, physiology and potential for perimenopause
Prior JC, 2011
Fracture Risk · Risk Factors
Spine-hip T-score difference predicts major osteoporotic fracture risk independent of FRAX(®): a population-based report from CAMOS
Leslie WD et al., 2011
Transition Physiology · Cycle Changes
The endocrinology of perimenopause: need for a paradigm shift
Prior JC et al., 2011
Nutrition and Metabolic Health · Eating Disorders and Underfueling
"Relationships among cognitive dietary restraint, subclinical ovulation disturbances, cortisol and 2‐yr change in bone density in premenopausal women"
Bedford JL et al., 2010
Nutrition and Metabolic Health · Eating Disorders and Underfueling
A prospective exploration of cognitive dietary restraint, subclinical ovulatory disturbances, cortisol, and change in bone density over two years in healthy young women
Bedford JL et al., 2010
Hormones and Bone · Estrogen and Bone
Bone changes and fracture related to menstrual cycles and ovulation
Kalyan S et al., 2010
Hormonal Agents · Progesterone and Progestins
Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy
Kalyan S et al., 2010
Hormonal Agents · Progesterone and Progestins
Community pharmacists' therapeutic recommendations for heavy flow, androgen excess, fragility fractures and night sweats in menstruating women
Marks M et al., 2010
Fracture Risk · Risk Factors
Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture risk
Langsetmo L et al., 2010
Nutrition and Metabolic Health · Dietary Patterns
Dietary patterns in Canadian men and women ages 25 and older: relationship to demographics, body mass index, and bone mineral density
Langsetmo L et al., 2010
Bone Mineral Density · Measurement
Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians
Kingwell E et al., 2010
Evaluation of methods and costs associated with recruiting healthy women volunteers to a study of ovulation
Battistella E et al., 2010
Bone Mineral Density · Peak Bone Mass
Normative bone mineral density z-scores for Canadians aged 16 to 24 years: the Canadian Multicenter Osteoporosis Study
Zhou W et al., 2010
Osteoporosis · Diagnosis and Treatment
Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis
Berger C et al., 2010
Hormones and Bone · Estrogen and Bone
Progesterone and bone: actions promoting bone health in women
Seifert-Klauss V et al., 2010
Bone Mineral Density · Measurement
Using the same bone density reference database for men and women provides a simpler estimation of fracture risk
Langsetmo L et al., 2010
Bone Mineral Density · Measurement
Association between change in BMD and fragility fracture in women and men
Berger C et al., 2009
Methods · Sympto-Thermal Method
Detecting evidence of luteal activity by least-squares quantitative basal temperature analysis against urinary progesterone metabolites and the effect of wake-time variability
Bedford JL et al., 2009
Fracture Risk · Prevention
Effectiveness of antiresorptives for the prevention of nonvertebral low-trauma fractures in a population-based cohort of women
Langsetmo LA et al., 2009
Measurement and Statistics · Instrument Development and Validation
Health-related quality of life in Canadian adolescents and young adults: normative data using the SF-36
Hopman WM et al., 2009
Premenstrual Disorders · Cyclical Symptom Patterns
Ovulation disturbances and mood across the menstrual cycles of healthy women
Harvey AT et al., 2009
Parity and subfertility effects of continuous oral contraceptive on fertility are important
Hitchcock CL et al., 2009
Osteoporosis · Diagnosis and Treatment
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study
Ioannidis G et al., 2009
Osteoporosis · Diagnosis and Treatment
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study
Papaioannou A et al., 2009
Fracture Risk · Risk Factors
Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk
Chen P et al., 2009
Age at menarche in the Canadian population: secular trends and relationship to adulthood BMI
Harris MA et al., 2008
Guidelines by Issuing Body · Specialty and Consensus Panels
Dual-Energy X-Ray Absorptiometry Technical issues: the 2007 ISCD Official Positions
Simonelli C et al., 2008
Fracture Risk · Risk Factors
Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older
Langsetmo L et al., 2008
Osteoporosis · Diagnosis and Treatment
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study
Papaioannou A et al., 2008
A pilot study of the feasibility of long-term human bone balance during perimenopause using a 41Ca tracer
Hui S et al., 2007
Changes in body mass index in Canadians over a five-year period: results of a prospective, population-based study
Hopman WM et al., 2007
Fracture Risk · Risk Factors
Changes to osteoporosis prevalence according to method of risk assessment
Richards JB et al., 2007
Fracture Risk · Risk Factors
Effect of selective serotonin reuptake inhibitors on the risk of fracture
Richards JB et al., 2007
Hormone Therapy · Benefits and Risks
Effectiveness of ERr 731 in the management of symptomatic perimenopause: clinical significance
Prior JC et al., 2007
Osteoporosis · Diagnosis and Treatment
Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study
Prior J et al., 2007
Hormones and Bone · Estrogen and Bone
FSH and bone--important physiology or not?
Prior JC, 2007
Hormone Therapy · Benefits and Risks
Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy
Prior JC et al., 2007
The association between body mass index and health-related quality of life: data from CaMos, a stratified population study
Hopman WM et al., 2007
Transition Physiology · Symptom Patterns
Perimenopause lost—reframing the end of menstruation
Prior JC, 2006
Unsuccessful attempt to demonstrate progesterone's bone formation actions
Prior JC et al., 2006
Osteoporosis · Diagnosis and Treatment
What is the number of older Canadians needed to screen by measurement of bone density to detect an undiagnosed case of osteoporosis? a population-based study from CaMos
Sawka AM et al., 2006
Cycle Physiology · Hormonal Regulation
Changes in pulmonary transfer factor with menstrual cycle phase
Bacon CJ et al., 2005
Ovarian Hormones · Estrogen
Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation
Prior JC, 2005
Fracture Risk · Risk Factors
Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos)
Papaioannou A et al., 2005
Oral Contraceptives · Cancer Risk
Evidence about extending the duration of oral contraceptive use to suppress menstruation
Hitchcock CL et al., 2004
Bone Mineral Density · Measurement
Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study
Hanley DA et al., 2003
Transition Physiology · Symptom Patterns
Cyclicity of breast tenderness and night-time vasomotor symptoms in mid-life women: information collected using the Daily Perimenopause Diary
Hale GE et al., 2003
Oral Contraceptives · Metabolic Effects
Decreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: a randomised controlled trial
Lebrun CM et al., 2003
Bone Mineral Density · Measurement
Osteoporosis: What a clinician expects to learn from a patient's bone density examination
Lentle BC et al., 2003
Osteoporosis · Diagnosis and Treatment
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos)
Adachi JD et al., 2003
Osteoporosis · Diagnosis and Treatment
Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial
Carter ND et al., 2002
Supplements and Botanicals · Herbal and Botanical Products
Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial
Van Patten CL et al., 2002
Ovulation Physiology · Anovulation
The ageing female reproductive axis II: ovulatory changes with perimenopause
Prior JC, 2002
Stress and Allostatic Load · Stress and Ovulation
Cognitive dietary restraint is associated with higher urinary cortisol excretion in healthy premenopausal women
McLean JA et al., 2001
Nutrition and Metabolic Health · Eating Disorders and Underfueling
Dietary restraint, exercise, and bone density in young women: are they related?
McLean JA et al., 2001
Bone Mineral Density · Peak Bone Mass
Eating attitudes and habitual calcium intake in peripubertal girls are associated with initial bone mineral content and its change over 2 years
Barr SI et al., 2001
Bone Mineral Density · Peak Bone Mass
Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study
Prior JC et al., 2001
Hormones and Bone · Estrogen and Bone
Perimenopausal bone loss: more than estrogen depletion
Prior JC et al., 2001
Nutrition and Metabolic Health · Dietary Patterns
Physiologic effects of lowering caloric intake in nonhuman primates and nonobese humans
Roberts SB et al., 2001
Osteoporosis · Diagnosis and Treatment
Results of a 10 week community based strength and balance training programme to reduce fall risk factors: a randomised controlled trial in 65-75 year old women with osteoporosis
Carter ND et al., 2001
Osteoporosis · Diagnosis and Treatment
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada
Adachi JD et al., 2001
Bone Mineral Density · Peak Bone Mass
Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in prepubescent and early pubescent children
McKay HA et al., 2000
Osteoporosis · Diagnosis and Treatment
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos)
Tenenhouse A et al., 2000
Hormone Therapy · Benefits and Risks
Preserved forearm endothelial responses with acute exposure to progesterone: A randomized cross-over trial of 17-beta estradiol, progesterone, and 17-beta estradiol with progesterone in healthy menopausal women
Mather KJ et al., 2000
Osteoporosis · Diagnosis and Treatment
Research Notes: The Canadian Multicentre Osteoporosis Study (CaMos): Background, Rationale, Methods
Kreiger N et al., 1999
Bone Mineral Density · Peak Bone Mass
Running and ovulation positively change cancellous bone in premenopausal women
Petit MA et al., 1999
Ovulation and spinal bone mineral density
Petit MA et al., 1998
Transition Physiology · Cycle Changes
Perimenopause: the complex endocrinology of the menopausal transition
Prior JC, 1998
Bone Mineral Density · Peak Bone Mass
Spinal bone mineral density in premenopausal vegetarian and nonvegetarian women: cross-sectional and prospective comparisons
Barr SI et al., 1998
Bone Mineral Density · Measurement
EXERCISE-ASSOCIATED CANCELLOUS BONE CHANGE: POSITIVE EFFECT OF OVULATION 1116
Petit MA et al., 1997
Hormones and Bone · Estrogen and Bone
Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate
Prior JC et al., 1997
An unsuccessful attempt to relate ovulatory disturbances to changes in bone density
Petit MA et al., 1996
Exercise-associated menstrual disturbances
Prior JC, 1996 Book chapter
Bone Mineral Density · Measurement
Ovulatory premenopausal women lose cancellous spinal bone: a five year prospective study
Prior JC et al., 1996
Guidelines by Clinical Area · Bone and Endocrine Guidelines
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 5. Physical activity as therapy for osteoporosis
Prior JC et al., 1996
Ovarian Hormones · Estrogen
Effects of menstrual cycle phase on athletic performance
Lebrun CM et al., 1995
Cycle Physiology · Luteal Phase
Energy intakes are higher during the luteal phase of ovulatory menstrual cycles
Barr SI et al., 1995
Hormonal Agents · Progesterone and Progestins
Medroxyprogesterone increases basal temperature: a placebo-controlled crossover trial in postmenopausal women
Prior JC et al., 1995
Amenorrhea and Anovulation: Risk Factors for Osteoporosis That Precede Menopause
Prior JC et al., 1994 Book chapter
Calcium resorption from bone in a human studied by 41CA tracing
Johnson RR et al., 1994
Hormonal Agents · Progesterone and Progestins
Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances
Prior JC et al., 1994
Hormonal Agents · Progesterone and Progestins
No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: double-blind, placebo-controlled, crossover trial
Prior JC et al., 1994
Progesterone and Its Role in Bone Remodelling
Prior JC, 1994 Book chapter
Nutrition and Metabolic Health · Eating Disorders and Underfueling
Restrained eating and ovulatory disturbances: possible implications for bone health
Barr SI et al., 1994
Infant Feeding · Milk Supply
Serum lactogens possessed normal bioactivity in patients with lactation insufficiency
Livingstone VH et al., 1994
The menstrual cycle: effects on bone in menopausal women
Barr SI et al., 1994 Book chapter
Cycle Disorders · Ovulatory Disturbances
Vegetarian vs nonvegetarian diets, dietary restraint, and subclinical ovulatory disturbances: prospective 6-mo study
Barr SI et al., 1994
Neuroendocrinology · Hypothalamic Amenorrhea
Reproduction for the athletic woman. New understandings of physiology and management
Prior JC et al., 1992
Ovulation disturbances and exercise training
Prior JC et al., 1991
Measurement and Statistics · Instrument Development and Validation
Determination of luteal phase length by quantitative basal temperature methods: validation against the midcycle LH peak
Prior JC et al., 1990
Hormones and Bone · Estrogen and Bone
Progesterone as a bone-trophic hormone
Prior JC, 1990
Hormones and Bone · Estrogen and Bone
Spinal bone loss and ovulatory disturbances
Prior JC et al., 1990
Environmental Exposures · Heavy Metals
Acute arsenic toxicity--an opaque poison
Gray JR et al., 1989
Physical Activity · Exercise and Ovulation
Intense Exercise During the First Two Trimesters of Unapparent Pregnancy
Cohen GC et al., 1989
Hormonal Agents · Androgens and DHEA
Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism
Prior JC et al., 1989
Physicochemical characterization and functional activity of fibroid prolactin produced in cell culture
Chapitis J et al., 1988
Sleep and Circadian Health · Sleep Quality
Reversible reproductive dysfunction in men with obstructive sleep apnoea
Santamaria JD et al., 1988
Physical Activity · Exercise and Ovulation
Conditioning exercise and premenstrual symptoms
Prior JC et al., 1987
Physical Activity · Exercise and Ovulation
Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial
Prior JC et al., 1987
Neuroendocrinology · Hypothalamic Amenorrhea
Physical exercise and the neuroendocrine control of reproduction
Prior JC, 1987
Hormonal Agents · Androgens and DHEA
Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen
Prior JC et al., 1987
Physical Activity · Exercise and Ovulation
Conditioning exercise decreases premenstrual symptoms. A prospective controlled three month trial
Prior JC et al., 1986
Bioactive forms of serum lactogens: effects of treatment of prolactinoma patients with bromocriptine
Rennie PS et al., 1985
Ovarian Hormones · Progesterone
Gonadal steroids in athletic women contraception, complications and performance
Prior JC et al., 1985
Neuroendocrinology · Gonadotropins
Gonadotrophin-secreting pituitary tumour: report and review
Whitaker MD et al., 1985
Luteal Phase Defects and Anovulation: Adaptive Alterations Occurring with Conditioning Exercise
Prior JC, 1985
Is premenstrual syndrome exaggerated molimina?
Prior JC, 1984
Prolactin production from proliferative phase leiomyoma
Daly DC et al., 1984
Use of tactile techniques for self-monitoring of blood glucose in visually impaired patients with diabetes mellitus
Prior JC et al., 1984
Ovarian Hormones · Progesterone
Human myometrium: a new potential source of prolactin
Walters CA et al., 1983
Fracture Risk · Risk Factors
Dialysis encephalopathy and osteomalacic bone disease: a case-controlled study
Prior JC et al., 1982
Cycle Disorders · Ovulatory Disturbances
Menstrual cycle changes with marathon training: anovulation and short luteal phase
Prior JC et al., 1982
Reversible luteal phase changes and infertility associated with marathon training
Prior JC et al., 1982
Metabolic and Endocrine Agents · Corticosteroids
Hemodialysis patients with a unique mineralizing defect unresponsive to 1,25-dihydroxycholecalciferol. Dialysis osteomalacic syndrome
Cameron EC et al., 1980
Metabolic and Endocrine Agents · Corticosteroids
Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy
Prior JC et al., 1979
Hyperbradykininism: a new orthostatic syndrome
Streeten DH et al., 1972
Some aspects of the clinical communication of pain
Prior JC, 1967
